Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10112942 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Patent 10112942 was granted and assigned to Array Biopharma Inc. on October, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Array Biopharma Inc.

0

Current Assignee

Array Biopharma Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Andrew T. Metcalf0

Adam Cook0

Steven W. Andrews0

Tony P. Tang0

Yutong Jiang0

Barbara J. Brandhuber0

David A. Moreno0

Elizabeth A. McFaddin0

...

Date of Patent

October 30, 2018

0

Patent Application Number

158582400

Date Filed

December 29, 2017

0

Patent Citations Received

US Patent 10881652 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

US Patent 11666570 Diagnosis and regulation of epidermal differentiation and cancer cell activity

0

US Patent 11648243 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

0

US Patent 12102621 Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

0

US Patent 11963950 Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

0

US Patent 10441581 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

US Patent 10745419 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

0

US Patent 10786489 Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile

0

Patent Primary Examiner

Niloofar Rahmani

0

Patent abstract

Provided herein are compounds of the Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10112942 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool